← FDA Drug Approvals (Drugs@FDA)

DICLOXACILLIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-09-23

Drug application

FDA Application #

ANDA216845

Application type

Abbreviated New Drug Application (Generic)

Brand name

DICLOXACILLIN SODIUM

Generic name

DICLOXACILLIN SODIUM

Active ingredients

DICLOXACILLIN SODIUM

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2022-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown